Decker Robert J
SEC CIK 1798703 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | VP Corp. Ctrl | 27.8K | — | $9.28M | 32 | 2021-12-07 | 2026-02-27 |
Most active insiders at JNJ, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Duato Joaquin | CEO, COB, Dir | — | $66.84M |
| 2 | Wolk Joseph J | EVP, CFO | — | $21.77M |
| 3 | REED JOHN C | EVP, Innovative Medicine, R, D | — | $17.29M |
| 4 | Swanson James D. | EVP, CIO | — | $15.11M |
| 5 | Schmid Timothy | EVP, WW COB, MedTech | — | $15.08M |
| 6 | Broadhurst Vanessa | EVP, Gbl Corp Affairs | — | $7.30M |
| 7 | Forminard Elizabeth | EVP, CLO | — | $4.09M |
| 8 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | — | $3.95M |
| 9 | Wengel Kathryn E | EVP, Chief TO, Risk Off | — | $2.41M |
| 10 | Decker Robert J | VP Corp. Ctrl | — | $1.01M |
Transactions 32
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-03 16:21 | 2026-02-27 | JNJ | Johnson & Johnson | Decker Robert J | VP Corp. Ctrl | M - OptEx | $115.67 | +4,075 | 27.8K | +17% | +$471.4K |
| D | 2026-03-03 16:21 | 2026-02-27 | JNJ | Johnson & Johnson | Decker Robert J | VP Corp. Ctrl | S - Sale+OE | $247.87 | -4,075 | 23.7K | -15% | -$1.01M |
| DM | 2026-02-18 21:12 | 2026-02-13+ | JNJ | Johnson & Johnson | Decker Robert J | VP Corp. Ctrl | M - OptEx | $0.00 | +3,736 | 23.8K | +19% | $0 |
| DM | 2026-02-18 21:12 | 2026-02-13+ | JNJ | Johnson & Johnson | Decker Robert J | VP Corp. Ctrl | F - Tax | $244.35 | -1,055 | 23.7K | -4% | -$257.8K |
| D | 2025-02-26 18:42 | 2025-02-25 | JNJ | Johnson & Johnson | Decker Robert J | VP Corp. Ctrl | M - OptEx | $101.87 | +6,999 | 28.0K | +33% | +$713.0K |
| D | 2025-02-26 18:42 | 2025-02-25 | JNJ | Johnson & Johnson | Decker Robert J | VP Corp. Ctrl | S - Sale+OE | $165.88 | -6,999 | 21.0K | -25% | -$1.16M |
| DM | 2025-02-18 21:01 | 2025-02-13+ | JNJ | Johnson & Johnson | Decker Robert J | VP Corp. Ctrl | M - OptEx | $0.00 | +2,852 | 21.4K | +15% | $0 |
| DM | 2025-02-18 21:01 | 2025-02-14+ | JNJ | Johnson & Johnson | Decker Robert J | VP Corp. Ctrl | F - Tax | $156.46 | -824 | 21.0K | -4% | -$128.9K |
| D | 2024-09-03 16:48 | 2024-08-30 | JNJ | Johnson & Johnson | Decker Robert J | VP Corp. Ctrl | M - OptEx | $100.06 | +5,635 | 24.6K | +30% | +$563.8K |
| D | 2024-09-03 16:48 | 2024-08-30 | JNJ | Johnson & Johnson | Decker Robert J | VP Corp. Ctrl | S - Sale+OE | $165.06 | -5,635 | 19.0K | -23% | -$930.1K |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Johnson & Johnson | Decker Robert J | VP Corp. Ctrl | M - OptEx | $0.00 | +313 | 19.1K | +2% | $0 |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Johnson & Johnson | Decker Robert J | VP Corp. Ctrl | F - Tax | $157.85 | -86 | 19.0K | -0.5% | -$13.6K |
| DM | 2024-02-14 18:36 | 2024-02-12 | JNJ | Johnson & Johnson | Decker Robert J | VP Corp. Ctrl | M - OptEx | $0.00 | +1,912 | 19.3K | +11% | $0 |
| D | 2024-02-14 18:36 | 2024-02-12 | JNJ | Johnson & Johnson | Decker Robert J | VP Corp. Ctrl | F - Tax | $157.40 | -523 | 18.7K | -3% | -$82.3K |
| D | 2024-02-12 19:24 | 2024-02-08 | JNJ | Johnson & Johnson | Decker Robert J | VP Corp. Ctrl | M - OptEx | $0.00 | +655 | 17.6K | +4% | $0 |
| D | 2024-02-12 19:24 | 2024-02-08 | JNJ | Johnson & Johnson | Decker Robert J | VP Corp. Ctrl | F - Tax | $156.33 | -215 | 17.4K | -1% | -$33.6K |
| D | 2023-02-15 19:24 | 2023-02-13 | JNJ | Johnson & Johnson | Decker Robert J | VP Corp. Ctrl | A - Grant | $0.00 | +1,451 | 17.3K | +9% | $0 |
| D | 2023-02-15 19:24 | 2023-02-13 | JNJ | Johnson & Johnson | Decker Robert J | VP Corp. Ctrl | F - Tax | $162.01 | -397 | 16.9K | -2% | -$64.3K |
| D | 2023-02-14 16:35 | 2023-02-10 | JNJ | Johnson & Johnson | Decker Robert J | VP Corp. Ctrl | M - OptEx | $0.00 | +581 | 16.1K | +4% | $0 |
| D | 2023-02-14 16:35 | 2023-02-10 | JNJ | Johnson & Johnson | Decker Robert J | VP Corp. Ctrl | F - Tax | $162.08 | -191 | 15.9K | -1% | -$31.0K |
| D | 2022-11-21 16:33 | 2022-11-18 | JNJ | Johnson & Johnson | Decker Robert J | CAO, Ctrl | M - OptEx | $90.44 | +16.9K | 32.4K | +109% | +$1.53M |
| D | 2022-11-21 16:33 | 2022-11-18 | JNJ | Johnson & Johnson | Decker Robert J | CAO, Ctrl | S - Sale+OE | $175.00 | -16.9K | 15.5K | -52% | -$2.96M |
| D | 2022-05-31 17:21 | 2022-05-26 | JNJ | Johnson & Johnson | Decker Robert J | CAO, Ctrl | M - OptEx | $72.54 | +8,462 | 23.9K | +55% | +$613.8K |
| D | 2022-05-31 17:21 | 2022-05-26 | JNJ | Johnson & Johnson | Decker Robert J | CAO, Ctrl | S - Sale+OE | $180.00 | -8,462 | 15.5K | -35% | -$1.52M |
| D | 2022-03-17 16:30 | 2022-03-15 | JNJ | Johnson & Johnson | Decker Robert J | CAO, Ctrl | M - OptEx | $72.54 | +5,000 | 20.5K | +32% | +$362.7K |
| DM | 2022-03-17 16:30 | 2022-03-15 | JNJ | Johnson & Johnson | Decker Robert J | CAO, Ctrl | S - Sale+OE | $175.51 | -5,000 | 15.5K | -24% | -$877.5K |
| D | 2022-02-17 06:01 | 2022-02-15 | JNJ | Johnson & Johnson | Decker Robert J | CAO, Ctrl | M - OptEx | $0.00 | +903 | 15.7K | +6% | $0 |
| D | 2022-02-17 06:01 | 2022-02-15 | JNJ | Johnson & Johnson | Decker Robert J | CAO, Ctrl | F - Tax | $165.89 | -248 | 15.5K | -2% | -$41.1K |
| D | 2022-02-15 20:02 | 2022-02-14 | JNJ | Johnson & Johnson | Decker Robert J | CAO, Ctrl | M - OptEx | $0.00 | +866 | 15.1K | +6% | $0 |
| D | 2022-02-15 20:02 | 2022-02-14 | JNJ | Johnson & Johnson | Decker Robert J | CAO, Ctrl | F - Tax | $168.85 | -263 | 14.8K | -2% | -$44.4K |
| D | 2021-12-09 16:43 | 2021-12-07 | JNJ | Johnson & Johnson | Decker Robert J | CAO, Ctrl | M - OptEx | $72.54 | +5,000 | 19.2K | +35% | +$362.7K |
| D | 2021-12-09 16:43 | 2021-12-07 | JNJ | Johnson & Johnson | Decker Robert J | CAO, Ctrl | S - Sale+OE | $163.21 | -5,000 | 14.2K | -26% | -$816.0K |
Purchase Sale Sale after option exercise All abbreviations